Preliminary Evidence Suggests Japanese Acupuncture and Moxibustion May Ease Nerve Pain in Breast Cancer Survivors

A single-center, single-arm study led by Hiroto Ishiki of the National Cancer Center Hospital in Tokyo, published in the journal *Supportive Care in Cancer*, has reported promising preliminary evidence that a traditional, multimodal form of Japanese acupuncture and moxibustion (MJAM) could reduce chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors. This offers a potential non-drug option for a painful and often disabling condition that currently has limited established treatments.